Myeloproliferative Neoplasm, Not Otherwise Specified
specificThis subgroup of myeloproliferative neoplasms includes cases which do not meet the morphologic criteria of any of the defined myeloproliferative neoplasms, or which have characteristics that overlap at least two of the myeloproliferative neoplasms.
10
Centers
10
Active Trials
—
Cancer Funding
Top Centers for Myeloproliferative Neoplasm, Not Otherwise Specified(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 55.0 |
| 2 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 55.0 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 55.0 |
| 4 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 55.0 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 55.0 |
| 6 | NCI Clinical Active Research Program | 55.0 |
| 7 | NCI Comprehensive Active Research Program | 55.0 |
| 8 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 55.0 |
| 9 | University of Illinois Cancer CenterChicago, IL Active Research Program | 55.0 |
| 10 | Cancer Center at IllinoisUrbana, IL Active Research Program | 55.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →